{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:29:59Z","timestamp":1782534599503,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02220-2","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T11:03:30Z","timestamp":1698404610000},"page":"1091-1100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-7105","authenticated-orcid":false,"given":"D.","family":"Santi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cacciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scipio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bichiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Profeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. R. M.","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lanfranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Manieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"issue":"3","key":"2220_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40618-021-01694-2","volume":"45","author":"AD Fisher","year":"2022","unstructured":"Fisher AD et al (2022) SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people, (in eng). J Endocrinol Invest 45(3):657\u2013673. https:\/\/doi.org\/10.1007\/s40618-021-01694-2","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2220_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10508-009-9532-4","volume":"39","author":"HF Meyer-Bahlburg","year":"2010","unstructured":"Meyer-Bahlburg HF (2010) From mental disorder to iatrogenic hypogonadism: dilemmas in conceptualizing gender identity variants as psychiatric conditions, (in eng). Arch Sex Behav 39(2):461\u2013476. https:\/\/doi.org\/10.1007\/s10508-009-9532-4","journal-title":"Arch Sex Behav"},{"issue":"Suppl 1","key":"2220_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E et al (2022) Standards of care for the health of transgender and gender diverse people, version 8, (in eng). Int J Transgend Health 23(Suppl 1):S1-s259. https:\/\/doi.org\/10.1080\/26895269.2022.2100644","journal-title":"Int J Transgend Health"},{"issue":"2","key":"2220_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ecl.2019.01.001","volume":"48","author":"M Goodman","year":"2019","unstructured":"Goodman M, Adams N, Corneil T, Kreukels B, Motmans J, Coleman E (2019) Size and distribution of transgender and gender nonconforming populations: a narrative review, (in eng). Endocrinol Metab Clin North Am 48(2):303\u2013321. https:\/\/doi.org\/10.1016\/j.ecl.2019.01.001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10042","key":"2220_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0140-6736(16)00683-8","volume":"388","author":"S Winter","year":"2016","unstructured":"Winter S et al (2016) Transgender people: health at the margins of society, (in eng). Lancet (London, England) 388(10042):390\u2013400. https:\/\/doi.org\/10.1016\/s0140-6736(16)00683-8","journal-title":"Lancet (London, England)"},{"issue":"10042","key":"2220_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/s0140-6736(16)00682-6","volume":"388","author":"K Wylie","year":"2016","unstructured":"Wylie K, Knudson G, Khan SI, Bonierbale M, Watanyusakul S, Baral S (2016) Serving transgender people: clinical care considerations and service delivery models in transgender health, (in eng). Lancet (London, England) 388(10042):401\u2013411. https:\/\/doi.org\/10.1016\/s0140-6736(16)00682-6","journal-title":"Lancet (London, England)"},{"issue":"3","key":"2220_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/jsxmed\/qdac034","volume":"20","author":"P Exp\u00f3sito-Campos","year":"2023","unstructured":"Exp\u00f3sito-Campos P, G\u00f3mez-Balaguer M, Hurtado-Murillo F, Morillas-Ari\u00f1o C (2023) Evolution and trends in referrals to a specialist gender identity unit in Spain over 10 years (2012\u20132021), (in eng). J Sex Med 20(3):377\u2013387. https:\/\/doi.org\/10.1093\/jsxmed\/qdac034","journal-title":"J Sex Med"},{"issue":"12","key":"2220_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4158\/1934-2403-23.12.1437","volume":"23","author":"WC Hembree","year":"2017","unstructured":"Hembree WC et al (2017) Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline, (in eng). Endocr Pract Off J Am Coll Endocrinol Am Assoc Clini Endocrinol 23(12):1437. https:\/\/doi.org\/10.4158\/1934-2403-23.12.1437","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clini Endocrinol"},{"key":"2220_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/jcm9061609","volume":"9","author":"C Cocchetti","year":"2020","unstructured":"Cocchetti C, Ristori J, Romani A, Maggi M, Fisher AD (2020) Hormonal treatment strategies tailored to non-binary transgender individuals, (in eng). J Clin Med 9:6. https:\/\/doi.org\/10.3390\/jcm9061609","journal-title":"J Clin Med"},{"issue":"3","key":"2220_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","volume":"47","author":"PJ van Kesteren","year":"1997","unstructured":"van Kesteren PJ, Asscheman H, Megens JA, Gooren LJ (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones, (in eng). Clin Endocrinol 47(3):337\u2013342. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.2601068.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2220_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/eje-19-0463","volume":"182","author":"G Meyer","year":"2020","unstructured":"Meyer G, Mayer M, Mondorf A, Fl\u00fcgel AK, Herrmann E, Bojunga J (2020) Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria, (in eng). Eur J Endocrinol Eur Fed Endocr Soc 182(2):149\u2013156. https:\/\/doi.org\/10.1530\/eje-19-0463","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"6","key":"2220_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1365-2265.2009.03573.x","volume":"71","author":"W de Ronde","year":"2009","unstructured":"de Ronde W, ten Kulve J, Woerdeman J, Kaufman JM, de Jong FH (2009) Effects of oestradiol on gonadotrophin levels in normal and castrated men, (in eng). Clin Endocrinol 71(6):874\u2013879. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03573.x","journal-title":"Clin Endocrinol"},{"issue":"9","key":"2220_CR13","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1210\/jc.2007-0746","volume":"92","author":"A Mueller","year":"2007","unstructured":"Mueller A, Kiesewetter F, Binder H, Beckmann MW, Dittrich R (2007) Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals, (in eng). J Clin Endocrinol Metab 92(9):3470\u20133475. https:\/\/doi.org\/10.1210\/jc.2007-0746","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2220_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11154-018-9454-3","volume":"19","author":"MS Irwig","year":"2018","unstructured":"Irwig MS (2018) Cardiovascular health in transgender people, (in eng). Rev Endocr Metab Disord 19(3):243\u2013251. https:\/\/doi.org\/10.1007\/s11154-018-9454-3","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"2220_CR15","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S et al (2017) Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis, (in eng). J Clin Endocrinol Metab 102(11):3914\u20133923. https:\/\/doi.org\/10.1210\/jc.2017-01643","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2220_CR16","doi-asserted-by":"publisher","first-page":"e005597","DOI":"10.1161\/circoutcomes.119.005597","volume":"12","author":"T Alzahrani","year":"2019","unstructured":"Alzahrani T et al (2019) Cardiovascular disease risk factors and myocardial infarction in the transgender population, (in eng). Circ Cardiovasc Qual Outcomes 12(4):e005597. https:\/\/doi.org\/10.1161\/circoutcomes.119.005597","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"2220_CR17","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1038\/s41366-021-00935-x","volume":"45","author":"M Kyinn","year":"2021","unstructured":"Kyinn M, Banks K, Leemaqz SY, Sarkodie E, Goldstein D, Irwig MS (2021) Weight gain and obesity rates in transgender and gender-diverse adults before and during hormone therapy, (in eng). Int J Obes (Lond) 45(12):2562\u20132569. https:\/\/doi.org\/10.1038\/s41366-021-00935-x","journal-title":"Int J Obes (Lond)"},{"issue":"Supp 1","key":"2220_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1017\/s1041610202008074","volume":"13","author":"C MacKnight","year":"2001","unstructured":"MacKnight C, Rockwood K (2001) Use of the chronic disease score to measure comorbidity in the Canadian study of health and aging, (in eng). Int Psychogeriatr 13(Supp 1):137\u2013142. https:\/\/doi.org\/10.1017\/s1041610202008074","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"2220_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/aje\/kwi068","volume":"161","author":"JC McGregor","year":"2005","unstructured":"McGregor JC et al (2005) Utility of the chronic disease score and Charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms, (in eng). Am J Epidemiol 161(5):483\u2013493. https:\/\/doi.org\/10.1093\/aje\/kwi068","journal-title":"Am J Epidemiol"},{"issue":"2","key":"2220_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0895-4356(92)90016-g","volume":"45","author":"M Von Korff","year":"1992","unstructured":"Von Korff M, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data, (in eng). J Clin Epidemiol 45(2):197\u2013203. https:\/\/doi.org\/10.1016\/0895-4356(92)90016-g","journal-title":"J Clin Epidemiol"},{"key":"2220_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/andr.13353","author":"M Romeo","year":"2022","unstructured":"Romeo M, Spaggiari G, Nuzzo F, Granata ARM, Simoni M, Santi D (2022) Follicle-stimulating hormone effectiveness in male idiopathic infertility: what happens in daily practice? (in eng). Andrology. https:\/\/doi.org\/10.1111\/andr.13353","journal-title":"Andrology"},{"key":"2220_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fcell.2019.00382","volume":"7","author":"PY Zhang","year":"2019","unstructured":"Zhang PY, Yu Y (2019) Precise personalized medicine in gynecology cancer and infertility, (in eng). Front Cell Dev Biol 7:382. https:\/\/doi.org\/10.3389\/fcell.2019.00382","journal-title":"Front Cell Dev Biol"},{"key":"2220_CR23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fendo.2019.00181","volume":"10","author":"FJ Broekmans","year":"2019","unstructured":"Broekmans FJ (2019) Individualization of FSH doses in assisted reproduction: facts and fiction, (in eng). Front Endocrinol 10:181. https:\/\/doi.org\/10.3389\/fendo.2019.00181","journal-title":"Front Endocrinol"},{"issue":"12","key":"2220_CR24","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1210\/jc.2014-1919","volume":"99","author":"SM Rosenthal","year":"2014","unstructured":"Rosenthal SM (2014) Approach to the patient: transgender youth: endocrine considerations, (in eng). J Clin Endocrinol Metab 99(12):4379\u20134389. https:\/\/doi.org\/10.1210\/jc.2014-1919","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"2220_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000087751","volume":"64","author":"L Gooren","year":"2005","unstructured":"Gooren L (2005) Hormone treatment of the adult transsexual patient, (in eng). Horm Res 64(Suppl 2):31\u201336. https:\/\/doi.org\/10.1159\/000087751","journal-title":"Horm Res"},{"issue":"8","key":"2220_CR26","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1210\/jc.2002-021967","volume":"88","author":"E Moore","year":"2003","unstructured":"Moore E, Wisniewski A, Dobs A (2003) Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects, (in eng). J Clin Endocrinol Metab 88(8):3467\u20133473. https:\/\/doi.org\/10.1210\/jc.2002-021967","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2220_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1210\/jc.2007-1809","volume":"93","author":"LJ Gooren","year":"2008","unstructured":"Gooren LJ, Giltay EJ, Bunck MC (2008) Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience, (in eng). J Clin Endocrinol Metab 93(1):19\u201325. https:\/\/doi.org\/10.1210\/jc.2007-1809","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2220_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/bf01579291","volume":"18","author":"JC Prior","year":"1989","unstructured":"Prior JC, Vigna YM, Watson D (1989) Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism, (in eng). Arch Sex Behav 18(1):49\u201357. https:\/\/doi.org\/10.1007\/bf01579291","journal-title":"Arch Sex Behav"},{"issue":"1","key":"2220_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4158\/ep.9.1.12","volume":"9","author":"V Tangpricha","year":"2003","unstructured":"Tangpricha V, Ducharme SH, Barber TW, Chipkin SR (2003) Endocrinologic treatment of gender identity disorders, (in eng). Endocr Pract Off J Am Coll Endocrinol Am Assoc Clini Endocrinol 9(1):12\u201321. https:\/\/doi.org\/10.4158\/ep.9.1.12","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clini Endocrinol"},{"issue":"1","key":"2220_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/09540261.2015.1089217","volume":"28","author":"BA Jones","year":"2016","unstructured":"Jones BA, Haycraft E, Murjan S, Arcelus J (2016) Body dissatisfaction and disordered eating in trans people: a systematic review of the literature, (in eng). Int Rev Psychiatry 28(1):81\u201394. https:\/\/doi.org\/10.3109\/09540261.2015.1089217","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"2220_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10508-007-9307-8","volume":"38","author":"E G\u00f3mez-Gil","year":"2009","unstructured":"G\u00f3mez-Gil E, Trilla A, Salamero M, God\u00e1s T, Vald\u00e9s M (2009) Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain, (in eng). Arch Sex Behav 38(3):378\u2013392. https:\/\/doi.org\/10.1007\/s10508-007-9307-8","journal-title":"Arch Sex Behav"},{"issue":"2","key":"2220_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1743-6109.2012.03006.x","volume":"10","author":"AD Fisher","year":"2013","unstructured":"Fisher AD et al (2013) Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation, (in eng). J Sex Med 10(2):408\u2013419. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.03006.x","journal-title":"J Sex Med"},{"issue":"7","key":"2220_CR33","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/andr.13225","volume":"10","author":"D Santi","year":"2022","unstructured":"Santi D et al (2022) Qualitative and quantitative analysis of doctor-patient interactions during andrological consultations, (in eng). Andrology 10(7):1240\u20131249. https:\/\/doi.org\/10.1111\/andr.13225","journal-title":"Andrology"},{"issue":"4","key":"2220_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jsxm.2021.01.185","volume":"18","author":"C Cocchetti","year":"2021","unstructured":"Cocchetti C et al (2021) Does gender-affirming hormonal treatment affect 30-year cardiovascular risk in transgender persons? A two-year prospective European study (ENIGI), (in eng). J Sex Med 18(4):821\u2013829. https:\/\/doi.org\/10.1016\/j.jsxm.2021.01.185","journal-title":"J Sex Med"},{"issue":"5","key":"2220_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.endonu.2015.02.001","volume":"62","author":"C Quir\u00f3s","year":"2015","unstructured":"Quir\u00f3s C et al (2015) Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia, (in eng). Endocrinologia Y Nutricion Organo De La Sociedad Espanola De Endocrinologia Y Nutricion 62(5):210\u2013216. https:\/\/doi.org\/10.1016\/j.endonu.2015.02.001","journal-title":"Endocrinologia Y Nutricion Organo De La Sociedad Espanola De Endocrinologia Y Nutricion"},{"issue":"10","key":"2220_CR36","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/aogs.14227","volume":"100","author":"M Hilden","year":"2021","unstructured":"Hilden M et al (2021) Gender incongruence in Denmark, a quantitative assessment, (in eng). Acta Obstet Gynecol Scand 100(10):1800\u20131805. https:\/\/doi.org\/10.1111\/aogs.14227","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"2220_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.beem.2010.12.002","volume":"25","author":"S Bhasin","year":"2011","unstructured":"Bhasin S, Basaria S (2011) Diagnosis and treatment of hypogonadism in men, (in eng), best practice & research. Clin Endocrinol Metab 25(2):251\u2013270. https:\/\/doi.org\/10.1016\/j.beem.2010.12.002","journal-title":"Clin Endocrinol Metab"},{"issue":"5","key":"2220_CR38","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S et al (2018) Testosterone therapy in men with hypogonadism: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 103(5):1715\u20131744. https:\/\/doi.org\/10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"2220_CR39","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL et al (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial, (in eng). JAMA 291(14):1701\u20131712. https:\/\/doi.org\/10.1001\/jama.291.14.1701","journal-title":"JAMA"},{"issue":"5","key":"2220_CR40","doi-asserted-by":"publisher","first-page":"e2022317","DOI":"10.23750\/abm.v93i5.13719","volume":"93","author":"K Voutsadaki","year":"2022","unstructured":"Voutsadaki K, Matalliotakis M, Ladomenou F (2022) Hypogonadism in adolescent girls: treatment and long-term effects, (in eng). Acta Biomed 93(5):e2022317. https:\/\/doi.org\/10.23750\/abm.v93i5.13719","journal-title":"Acta Biomed"},{"issue":"9","key":"2220_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2015.112","volume":"11","author":"U Boehm","year":"2015","unstructured":"Boehm U et al (2015) Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism\u2013pathogenesis, diagnosis and treatment, (in eng). Nat Rev Endocrinol 11(9):547\u2013564. https:\/\/doi.org\/10.1038\/nrendo.2015.112","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2220_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/1471-0528.15433","volume":"126","author":"M Holm","year":"2019","unstructured":"Holm M et al (2019) Pattern of mortality after menopausal hormone therapy: long-term follow up in a population-based cohort, (in eng). BJOG An Int J Obstet Gynaecol 126(1):55\u201363. https:\/\/doi.org\/10.1111\/1471-0528.15433","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"6","key":"2220_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/aje\/kwx131","volume":"186","author":"SN Bhupathiraju","year":"2017","unstructured":"Bhupathiraju SN et al (2017) Hormone therapy use and risk of chronic disease in the nurses\u2019 health study: a comparative analysis with the women\u2019s health initiative, (in eng). Am J Epidemiol 186(6):696\u2013708. https:\/\/doi.org\/10.1093\/aje\/kwx131","journal-title":"Am J Epidemiol"},{"key":"2220_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-01067-z","author":"FJ Martinez-Martin","year":"2022","unstructured":"Martinez-Martin FJ et al (2022) Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy, (in eng). Hypertens Res. https:\/\/doi.org\/10.1038\/s41440-022-01067-z","journal-title":"Hypertens Res"},{"issue":"1","key":"2220_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","volume":"72","author":"MB Elamin","year":"2010","unstructured":"Elamin MB, Garcia MZ, Murad MH, Erwin PJ, Montori VM (2010) Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses, (in eng). Clin Endocrinol 72(1):1\u201310. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03632.x","journal-title":"Clin Endocrinol"},{"issue":"11","key":"2220_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1161\/circulationaha.118.038584","volume":"139","author":"NM Nota","year":"2019","unstructured":"Nota NM, Wiepjes CM, de Blok CJM, Gooren LJG, Kreukels BPC, den Heijer M (2019) Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy, (in eng). Circulation 139(11):1461\u20131462. https:\/\/doi.org\/10.1161\/circulationaha.118.038584","journal-title":"Circulation"},{"key":"2220_CR47","doi-asserted-by":"publisher","first-page":"718200","DOI":"10.3389\/fendo.2021.718200","volume":"12","author":"G Aranda","year":"2021","unstructured":"Aranda G et al (2021) Cardiovascular risk associated with gender affirming hormone therapy in transgender population, (in eng). Front Endocrinol 12:718200. https:\/\/doi.org\/10.3389\/fendo.2021.718200","journal-title":"Front Endocrinol"},{"issue":"6","key":"2220_CR48","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","volume":"8","author":"M Berra","year":"2006","unstructured":"Berra M et al (2006) Testosterone decreases adiponectin levels in female to male transsexuals, (in eng). Asian J Androl 8(6):725\u2013729. https:\/\/doi.org\/10.1111\/j.1745-7262.2006.00204.x","journal-title":"Asian J Androl"},{"issue":"8","key":"2220_CR49","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jsm.12571","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K et al (2014) Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence, (in eng). J Sex Med 11(8):1999\u20132011. https:\/\/doi.org\/10.1111\/jsm.12571","journal-title":"J Sex Med"},{"issue":"4","key":"2220_CR50","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.fertnstert.2021.07.1206","volume":"116","author":"P Pirtea","year":"2021","unstructured":"Pirtea P, Ayoubi JM, Desmedt S, T\u2019Sjoen G (2021) Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men, (in eng). Fertil Steril 116(4):936\u2013942. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.1206","journal-title":"Fertil Steril"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02220-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02220-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02220-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T07:20:17Z","timestamp":1713770417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02220-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["2220"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02220-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Ethics Committee of \u201cArea Vasta Emilia Nord\u201d (protocol number: AOU0024637\/19 of 12\/09\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The informed consent has been provided by patients enrolled.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}